US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 2, 2022 (4 years ago)

Losartan HCTZ 100/12.5 mg

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

What was recalled

Losartan HCTZ 100/12.5 mg, 90 count bottles NDC# 70518-2564-00 Repackaged NDC Original NDC # 68180-0216-09

Recalling firm
RemedyRepack Inc.
NDC code
70518-2564-00
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0887-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Losartan recalls

See all
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.

Strides Pharma Inc. NDC 64380-933-08 D-0895-2023
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

PD-Rx Pharmaceuticals, Inc. NDC 72789-165-90 D-1163-2022
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

PD-Rx Pharmaceuticals, Inc. NDC 72789-164-90 D-1162-2022